AusPAR: Tocilizumab (rch)

Australian Public Assessment Report

AusPAR

AusPAR: Tocilizumab (rch) [PDF, 928.76 KB]

AusPAR: Tocilizumab (rch) [Word, 1.6 MB]

Attachment: Product Information: Tocilizumab (rch) [PDF, 549.31 KB]

Attachment: Product Information: Tocilizumab (rch) [Word, 205.12 KB]

Attachment: Extract from Clinical Evaluation Report: Tocilizumab (rch) [PDF, 2.66 MB]

Attachment: Extract from Clinical Evaluation Report:Tocilizumab (rch) [Word, 5.06 MB]

Device/Product Name

Actemra

Active ingredients

Tocilizumab (rch)

AusPAR Date

4 June 2018

Published

14 June 2018

Submission Number

PM-2016-03548-1-3

Submission Type

Extension of indications

Decision

Approved